Physician

Charles L Ogburn, M.D.

According to 2025 Medicare claims, Charles Ogburn, M.D. (NPI: 1356312979) practices internal medicine in the Macon-Bibb County, GA market, with the plurality of this provider's patient population coming from Bibb, GA. This provider's primary affiliated billing organization is INTERNAL MEDICINE ASSOCIATES, P.C. (NPI: 1033180625; TIN: 58-1109078) and primary practice location at 31217-8034. Ogburn is affiliated with the Dependable Care Partners, Select (ACO ID: A5666), participating under the MSSP model.

Ogburn's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 473 traditional Medicare patients, billed 25,938 HCPCS/CPT codes, and received $602,813 in Medicare payments. The top billing code was 84443 (Blood test, thyroid stimulating hormone (tsh)). Part D data shows 11,196 prescription claims across 596 beneficiaries totaling $684,555 in drug costs, led by Eliquis (Apixaban). DME data shows 62 claims. Open Payments data shows 34 records totaling $664. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing did not follow a clear longitudinal pattern. Concurrently, Part D prescription costs have changed little. In contrast, DME billing represents a smaller volume and moved up and down with repeated peaks and valleys, starting at $9,141 and ending at $10,095.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	640	23,068	$588,156
2016	640	26,731	$519,391
2017	614	32,240	$484,223
2018	615	26,067	$418,875
2019	621	26,361	$431,566
2020	603	23,244	$550,199
2021	590	26,916	$775,190
2022	533	25,246	$739,088
2023	505	23,266	$591,400
2024	473	25,938	$602,813

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	544	11,777	$590,614
2016	575	12,016	$631,203
2017	563	12,170	$632,045
2018	580	11,488	$604,933
2019	577	11,368	$650,780
2020	575	10,743	$641,526
2021	567	10,011	$590,173
2022	576	10,249	$578,844
2023	567	10,490	$698,864
2024	596	11,196	$684,555

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	100	312	$4,835
2016	95	323	$4,516
2017	62	215	$3,644
2018	60	174	$2,885
2019	49	141	$2,679
2020	55	184	$5,099
2021	33	90	$4,060
2022	17	116	$8,490
2023	13	93	$7,443
2024	N/R	62	$6,123

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
84443	Blood test, thyroid stimulating hormone (tsh)	428	960	$16
80061	Blood test, lipids (cholesterol and triglycerides)	427	764	$13
80053	Blood test, comprehensive group of blood chemicals	433	1,050	$10
36415	Insertion of needle into vein for collection of blood sample	438	1,088	$9
84550	Uric acid level, blood	437	1,059	$4

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Eliquis	Apixaban	211	10,011	$178,907
Mounjaro	Tirzepatide	36	1,292	$46,769
Ozempic	Semaglutide	39	1,272	$35,538
Trulicity	Dulaglutide	30	1,012	$33,095
Entresto	Sacubitril/Valsartan	16	900	$19,710

Top 5 DME services in 2024

By Total Medicare Payment Amount.

HCPCS Code	HCPCS Description	Supplier Rental Indicator	Total Supplier Beneficiaries	Total Supplier Claims	Total Medicare Payment Amount
A4239	Supply allowance for non-adjunctive, non-implanted continuous glucose monitor (cgm), includes all supplies and accessories, 1 month supply = 1 unit of service	N	N/R	11	$5,000
K0003	Lightweight wheelchair	Y	N/R	23	$881
A4253	Blood glucose test or reagent strips for home blood glucose monitor, per 50 strips	N	N/R	28	$241

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	34	$664	Novo Nordisk Inc
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Charles L. Ogburn, M.D.?

Tedicare shows public-source Medicare data for Charles L. Ogburn, M.D. (NPI 1356312979), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Charles L. Ogburn, M.D. have ACO affiliation data?

Charles L. Ogburn, M.D. is shown with ACO affiliation data for Dependable Care Partners, Select (MSSP, ACO ID A5666).

What billing organization is linked to Charles L. Ogburn, M.D.?

Charles L. Ogburn, M.D. is linked to INTERNAL MEDICINE ASSOCIATES, P.C. (billing NPI 1033180625) in the available physician profile data.

Does Charles L. Ogburn, M.D. have Open Payments data?

Charles L. Ogburn, M.D. has 34 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.